Loading data for XBI — first visit, this takes a few seconds.
State Street SPDR S&P Bio... (XBI)
NYSEArca: XBI
· Real-Time Price · USD
164.17
+0.79 (0.48%)
At close: Aug 24, 2026, 8:00 PM
State Street SPDR S&P Biotech ETF (XBI) ETF Price, Holdings & Analysis
0.48% (1D)
No data available
| Bid | 165.91 |
| Market Cap | n/a |
| AUM | 9.63B |
| NAV | 165.68 |
| Beta | 1.14 |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Shares Out | n/a |
| Inception Date | Jan 31, 2006 |
| Ask | 167 |
| Volume | 9,963,689 |
| Avg. Volume (20D) | 8,996,001 |
| Open | 164.60 |
| Previous Close | 163.38 |
| Day's Range | 163.77 - 167.91 |
| 52-Week Range | 88.60 - 169.68 |
| Holdings | n/a |
| Expense Ratio | 0.35% |
About XBI
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").
Asset Class Equity
Ticker Symbol XBI
Inception Date Jan 31, 2006
Provider State Street Investment Management
Website Fund Home Page
Exchange NYSEArca
Top 10 Holdings 13.97% of assets
| Name | Symbol | Weight |
|---|---|---|
| Apogee Therapeutics ... | APGE | 1.65% |
| Oruka Therapeutics I... | ORKA | 1.53% |
| Dianthus Therapeutic... | DNTH | 1.42% |
| Erasca Inc | ERAS | 1.38% |
| Twist Bioscience Cor... | TWST | 1.37% |
| Kymera Therapeutics ... | KYMR | 1.34% |
| Spyre Therapeutics I... | SYRE | 1.33% |
| Revolution Medicines... | RVMD | 1.32% |
| Cg Oncology Inc | CGON | 1.32% |
| Protagonist Therapeu... | PTGX | 1.31% |
Dividends Dividend Yield 0.35%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Jun 22, 2026 | $0.1380 | n/a |
| Dec 22, 2025 | $0.4070 | n/a |
| Sep 22, 2025 | $0.0270 | n/a |
| Jun 23, 2025 | $0.0070 | n/a |
| Mar 24, 2025 | $0.0050 | n/a |
Page 1 of 2